Amniotic membrane transplantation may prevent ocular sequelae in Stevens-Johnson syndrome

LAS VEGAS — Ocular sequelae from Stevens-Johnson syndrome may be prevented with amniotic membrane transplantation when applied within the first 6 days after symptom onset, according to a paper presentation here. “Medical management is appropriate for patients who have more mild ocular manifestations, and this often includes various combinations of antibiotics, topical steroids, as well as cyclosporine and lubrication,” Amy Marie Cherof, MD, said at the American Academy of Ophthalmology annual meeting. “In addition, amniotic membrane transplantation has been shown in many studies, including those of our own, to decrease (Read more...)

Full Story →